Literature DB >> 26198474

Mutations in the Gardos channel (KCNN4) are associated with hereditary xerocytosis.

Edyta Glogowska1, Kimberly Lezon-Geyda1, Yelena Maksimova1, Vincent P Schulz1, Patrick G Gallagher2.   

Abstract

Hereditary xerocytosis (HX; MIM 194380) is an autosomal-dominant hemolytic anemia characterized by primary erythrocyte dehydration. In many patients, heterozygous mutations associated with delayed channel inactivation have been identified in PIEZO1. This report describes patients from 2 well-phenotyped HX kindreds, including from one of the first HX kindreds described, who lack predicted heterozygous PIEZO1-linked variants. Whole-exome sequencing identified novel, heterozygous mutations affecting the Gardos channel, encoded by the KCNN4 gene, in both kindreds. Segregation analyses confirmed transmission of the Gardos channel mutations with disease phenotype in affected individuals. The KCNN4 variants were different mutations in the same residue, which is highly conserved across species and within members of the small-intermediate family of calcium-activated potassium channel proteins. Both mutations were predicted to be deleterious by mutation effect algorithms. In sickle erythrocytes, the Gardos channel is activated under deoxy conditions, leading to cellular dehydration due to salt and water loss. The identification of KCNN4 mutations in HX patients supports recent studies that indicate it plays a critical role in normal erythrocyte deformation in the microcirculation and participates in maintenance of erythrocyte volume homeostasis.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26198474      PMCID: PMC4566808          DOI: 10.1182/blood-2015-07-657957

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  dbSNP: the NCBI database of genetic variation.

Authors:  S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

3.  Gardos pathway to sickle cell therapies?

Authors:  Clinton H Joiner
Journal:  Blood       Date:  2008-04-15       Impact factor: 22.113

4.  Sequence variants in three loci influence monocyte counts and erythrocyte volume.

Authors:  Manuel A R Ferreira; Jouke-Jan Hottenga; Nicole M Warrington; Sarah E Medland; Gonneke Willemsen; Robert W Lawrence; Scott Gordon; Eco J C de Geus; Anjali K Henders; Johannes H Smit; Megan J Campbell; Leanne Wallace; David M Evans; Margaret J Wright; Dale R Nyholt; Alan L James; John P Beilby; Brenda W Penninx; Lyle J Palmer; Ian H Frazer; Grant W Montgomery; Nicholas G Martin; Dorret I Boomsma
Journal:  Am J Hum Genet       Date:  2009-10-22       Impact factor: 11.025

5.  A mutation in the Gardos channel is associated with hereditary xerocytosis.

Authors:  Raphael Rapetti-Mauss; Caroline Lacoste; Véronique Picard; Corinne Guitton; Elise Lombard; Marie Loosveld; Vanessa Nivaggioni; Nathalie Dasilva; David Salgado; Jean-Pierre Desvignes; Christophe Béroud; Patrick Viout; Monique Bernard; Olivier Soriani; Henri Vinti; Valérie Lacroze; Madeleine Feneant-Thibault; Isabelle Thuret; Hélène Guizouarn; Catherine Badens
Journal:  Blood       Date:  2015-07-06       Impact factor: 22.113

6.  Identification of biologically relevant enhancers in human erythroid cells.

Authors:  Mack Y Su; Laurie A Steiner; Hannah Bogardus; Tejaswini Mishra; Vincent P Schulz; Ross C Hardison; Patrick G Gallagher
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

7.  Congenital hemolytic anemia associated with dehydrated erythrocytes and increased potassium loss.

Authors:  B E Glader; N Fortier; M M Albala; D G Nathan
Journal:  N Engl J Med       Date:  1974-09-05       Impact factor: 91.245

8.  Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis.

Authors:  Ryan Zarychanski; Vincent P Schulz; Brett L Houston; Yelena Maksimova; Donald S Houston; Brian Smith; Jesse Rinehart; Patrick G Gallagher
Journal:  Blood       Date:  2012-04-23       Impact factor: 22.113

9.  Local membrane deformations activate Ca2+-dependent K+ and anionic currents in intact human red blood cells.

Authors:  Agnieszka Dyrda; Urszula Cytlak; Anna Ciuraszkiewicz; Agnieszka Lipinska; Anne Cueff; Guillaume Bouyer; Stéphane Egée; Poul Bennekou; Virgilio L Lew; Serge L Y Thomas
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

10.  Xerocytosis is caused by mutations that alter the kinetics of the mechanosensitive channel PIEZO1.

Authors:  Chilman Bae; Radhakrishnan Gnanasambandam; Chris Nicolai; Frederick Sachs; Philip A Gottlieb
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

View more
  40 in total

1.  Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis.

Authors:  Edyta Glogowska; Eve R Schneider; Yelena Maksimova; Vincent P Schulz; Kimberly Lezon-Geyda; John Wu; Kottayam Radhakrishnan; Siobán B Keel; Donald Mahoney; Alison M Freidmann; Rachel A Altura; Elena O Gracheva; Sviatoslav N Bagriantsev; Theodosia A Kalfa; Patrick G Gallagher
Journal:  Blood       Date:  2017-07-17       Impact factor: 22.113

2.  Gardos channelopathy: functional analysis of a novel KCNN4 variant.

Authors:  Elisa Fermo; David Monedero-Alonso; Polina Petkova-Kirova; Asya Makhro; Laurent Pérès; Guillaume Bouyer; Anna Paola Marcello; Filomena Longo; Giovanna Graziadei; Wilma Barcellini; Anna Bogdanova; Stephane Egee; Lars Kaestner; Paola Bianchi
Journal:  Blood Adv       Date:  2020-12-22

3.  Red blood cell Gardos channel (KCNN4): the essential determinant of erythrocyte dehydration in hereditary xerocytosis.

Authors:  Raphaël Rapetti-Mauss; Véronique Picard; Corinne Guitton; Khaldoun Ghazal; Valérie Proulle; Catherine Badens; Olivier Soriani; Loïc Garçon; Hélène Guizouarn
Journal:  Haematologica       Date:  2017-06-15       Impact factor: 9.941

4.  Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.

Authors:  Christiane K Bauer; Pauline E Schneeberger; Fanny Kortüm; Janine Altmüller; Fernando Santos-Simarro; Laura Baker; Jennifer Keller-Ramey; Susan M White; Philippe M Campeau; Karen W Gripp; Kerstin Kutsche
Journal:  Am J Hum Genet       Date:  2019-05-30       Impact factor: 11.025

5.  Insight into GATA1 transcriptional activity through interrogation of cis elements disrupted in human erythroid disorders.

Authors:  Aoi Wakabayashi; Jacob C Ulirsch; Leif S Ludwig; Claudia Fiorini; Makiko Yasuda; Avik Choudhuri; Patrick McDonel; Leonard I Zon; Vijay G Sankaran
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-04       Impact factor: 11.205

6.  Senicapoc: a potent candidate for the treatment of a subset of hereditary xerocytosis caused by mutations in the Gardos channel.

Authors:  Raphael Rapetti-Mauss; Olivier Soriani; Henri Vinti; Catherine Badens; Hélène Guizouarn
Journal:  Haematologica       Date:  2016-07-21       Impact factor: 9.941

7.  Next generation research and therapy in red blood cell diseases.

Authors:  Roberta Russo; Immacolata Andolfo; Achille Iolascon
Journal:  Haematologica       Date:  2016-05       Impact factor: 9.941

8.  Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures.

Authors:  Chia-Hsueh Lee; Roderick MacKinnon
Journal:  Science       Date:  2018-05-04       Impact factor: 47.728

Review 9.  New insights on hereditary erythrocyte membrane defects.

Authors:  Immacolata Andolfo; Roberta Russo; Antonella Gambale; Achille Iolascon
Journal:  Haematologica       Date:  2016-10-18       Impact factor: 9.941

10.  PIEZO1 gene mutation in a Japanese family with hereditary high phosphatidylcholine hemolytic anemia and hemochromatosis-induced diabetes mellitus.

Authors:  Shinsaku Imashuku; Hideki Muramatsu; Takashi Sugihara; Yusuke Okuno; Xinan Wang; Kenichi Yoshida; Ayako Kato; Koichi Kato; Yasuaki Tatsumi; Ai Hattori; Shinya Kita; Keishi Oe; Atsushi Sueyoshi; Takeshi Usui; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Seishi Ogawa; Seiji Kojima; Hitoshi Kanno
Journal:  Int J Hematol       Date:  2016-03-14       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.